Analisis in-silico Peptida Berasaskan Epitop Daripada Protein-Protein Imunogen Burkholderia pseudomallei


  • Yi Wan Seow Jabatan Sains Biologi dan Bioteknologi, Fakulti Sains dan Teknologi, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia
  • Zhi Yun Tan Jabatan Sains Biologi dan Bioteknologi, Fakulti Sains dan Teknologi, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia
  • Sylvia Chieng Jabatan Sains Biologi dan Bioteknologi, Fakulti Sains dan Teknologi, Universiti Kebangsaan Malaysia, 43600 Bangi, Selangor, Malaysia


Burkholderia pseudomallei, ELISA, melioidosis, peptide, serodiagnosis


Melioidosis is an infectious disease caused by the gram-negative bacterium Burkholderia pseudomallei. This disease is associated with high human mortality rate, especially in tropical and subtropical regions. Rapid diagnosis is crucial in ensuring proper management and treatment of the disease with effective antibiotics. Currently, melioidosis diagnosis, bacterial culture is time consuming, difficult, and not sensitive, while IHA is hindered by high antibody background in healthy population and ELISA lacks standardization and is hindered by antigen inconsistency. To improve the current diagnosis method for melioidosis, this research aims to identify, screen, and develop epitope-spanning peptides to be used as standardized B. pseudomallei antigen in serodiagnosis of melioidosis. Peptides are favoured as they are more stable, and they offer effective and rapid antibody detection. Using in silico analysis, a pool of 154 B. pseudomallei proteins previously reported as immunogenic were screened and ranked based on their antigenicity, subcellular localization, stability, adhesive properties, and ability to interact with class I and class II major histocompatibility complex (MHC). The selected candidate from the analysis, BPSS0908 and BPSL2152 were then taken for further analysis to identify linear B-cell epitopes using several sequence-based B-cell epitope prediction tools. Consensus sequences that are confidently predicted by more than two prediction tools and are longer than 15 amino acids were then selected as linear B-cell epitopes. Through ELISA analysis, low sensitivity was demonstrated by the epitope-spanning peptides as compared to B. pseudomallei crude lysate. However, high specificity of 100% was observed for all tested peptides. The low sensitivity demonstrated by the peptides in ELISA could be due to lack of 3-dimensional structure which is needed for a stable antigen-antibody binding.


Download data is not yet available.


Metrics Loading ...


Bergamaschi, G., Fassi, E.M.A., Romanato, A., D’Annessa, I., Odinolfi, M.T., Brambilla, D., Damin, F., Chiari, M., Gori, A., Colombo, G. & Cretich, M. 2019. Computational analysis of dengue virus envelope protein (E) reveals an epitope with flavivirus immunodiagnostic potential in peptide microarrays. International Journal of Molecular Sciences 20(8): 1-13. DOI:

Chaichana, P., Jenjaroen, K., Amornchai, P., Chumseng, S., Langla, S., Rongkard, P., Sumonwiriya, M., Jeeyapant, A., Chantratita, N., Teparrukkul, P., Limmathurotsakul, D., Day, N.P.J., Wuthiekanun, V. & Dunachie, S.J. 2018. Antibodies in melioidosis: The role of the indirect hemagglutination assay in evaluating patients and exposed populations. The American Journal of Tropical Medicine and Hygiene, 99(6): 1378-1385. DOI:

Chen, J., Liu, H., Yang, J. & Chou, K.C. 2007. Prediction of linear B-cell epitopes using amino acid pair antigenicity scale. Amino Acids, 33(3): 423-428. DOI:

Chieng, S., Mohamed, R. & Nathan, S. 2015. Transcriptome analysis of Burkholderia pseudomallei T6SS identifies Hcp1 as a potential serodiagnostic marker. Microbial Pathogenesis, 79: 47-56. DOI:

Cretich, M., Gori, A., D’Annessa, I., Chiari, M. & Colombo, G. 2019. Peptides for infectious diseases: From probe design to diagnostic microarrays. Antibodies, 8(1): 23. DOI:

Demolombe, V., de Brevern, A.G., Felicori, L., Nguyen, C., de Avila, R.A.M., Valera, L., Jardin-Watelet, B., Lavigne, G., Lebreton, A., Molina, F. & Moreau, V. 2019. PEPOP 2.0: New approaches to mimic non-continuous epitopes. BMC Bioinformatics, 20: 387. DOI:

Dong, Y., Dai, T., Wei, Y., Zhang, L., Zheng, M. & Zhou, F. 2020. A systematic review of SARS-CoV-2 vaccine candidates. Signal Transduction and Targeted Therapy, 5: 237. DOI:

Doytchinova, I.A. & Flower, D.R. 2007. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics, 8: 4. DOI:

Duthie, M.S., Raychaudhuri, R., Tutterrow, Y.L., Misquith, A., Bowman, J., Casey, A., Balagon, M.F., Maghanoy, A., Beltran-Alzate, J.C., Romero-Alzate, M., Cardona-Castro, N. & Reed, S.G. 2014. A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate. Diagnostic Microbiology and Infectious Disease, 79(2): 233-239. DOI:

Ellert-Miklaszewska, A., Poleszak, K. & Kaminska, B. 2017. Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment. Future Medicinal Chemistry, 9(2): 199-221. DOI:

El-Manzalawy, Y., Dobbs, D. & Honavar, V. 2008. Predicting linear B-cell epitopes using string kernels. Journal of Molecular Recognition 21(4): 243-255. DOI:

Felgner, P.L., Kayala, M.A., Vigil, A., Burk, C., Nakajima-Sasaki, R., Pablo, J., Molina, D.M., Hirst, S., Chew, J.S.W., Wang, D., Tan, G., Duffield, M., Yang, R., Neel, J., Chantratita, N., Bancroft, G., Lertmemongkolchai, G., Davies, D.H., Baldi, P., Peacock, S. & Titball, R.W. 2009. A Burkholderia pseudomallei protein microarray reveals serodiagnostic and cross-reactive antigens. Proceedings of the National Academy of Sciences of the United States of America, 106(32): 13499-13504. DOI:

Gassiep, I., Armstrong, M. & Norton, R. 2020. Human melioidosis. Clinical Microbiology Reviews, 33(2): e00006-19. DOI:

Gasteiger, E., Hoogland, C., Gattiker, A., Duvaud, S., Wilkins, M.R., Appel, R.D. & Bairoch, A. 2005. Protein identification and analysis tools on the ExPasy server. In: The Proteomics Protocols Handbook. J.M. Walker (Ed.) Humana Press, Totowa, N.J. pp. 571-607. DOI:

He, Y., Xiang, Z. & Mobley, H.L.T. 2010. Vaxign: The first web-based vaccine design program for reverse vaccinology and applications for vaccine development. Journal of Biomedicine and Biotechnology, 2010: 297505. DOI:

Heyduk, E., Hickey, R., Pozzi, N. & Heyduk, T. 2018. Peptide ligand-based ELISA reagents for antibody detection. Analytical Biochemistry, 559: 55-61. DOI:

Hoffmaster, A.R., Aucoin, D., Baccam, P., Baggett, H.C., Baird, R., Bhengsri, S., Blaney, D.D., Brett, P.J., Brooks, T.J.G., Brown, K.A., Chantratita, N., Cheng, A.C., Dance, D.A.B., Decuypere, S., Defenbaugh, D., Gee, J.E., Houghton, R., Jorakate, P., Lertmemongkolchai, G., Limmathurotsaku, D., Merlin, T.L., Mukhopadhyay, C., Norton, R., Peacock, S.J., Rolim, D.B., Simpson, A.J., Steinmetz, I., Stoddard, R.A., Stokes, M.M., Sue, D., Tuanyok, A., Whistler, T., Wuthiekanun, V. & Walke, H.T. 2015. Melioidosis diagnostic workshop, 20131. Emerging Infectious Diseases, 21(2): 1-9. DOI:

Holden, M.T.G., Titball, R.W., Peacock, S.J., Cerdeño-Tárraga, A.M., Atkins, T., Crossman, L.C., Pitt, T., Churcher, C., Mungall, K., Bentley, S.D., Sebaihia, M., Thomson, N.R., Bason, M., Beacham, I.R., Brooks, K., Brown, K.A., Brown, N.F., Challis, G.L., Cherevach, I., Chillingworth, T., Cronin, A., Crossett, B., Davis, P., DeShazer, D., Feltwell, T., Fraser, A., Hance, Z., Hauser, H., Holroyd, S., Jagels, K., Keith, K.E., Maddison, M., Moule, S., Price, C., Quail, M.A., Rabbinowitsch, E., Rutherford, K., Sanders, M., Simmonds, M., Songsivilai, S., Stevens, K., Tumapa, S., Vesaratchavest, M., Whitehead, S., Yeats, C., Barrell, B.G., Oyston, P.C.F. & Parkhill, J. 2004. Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proceedings of the National Academy of Sciences of the United States of America, 101(39): 14240-14245. DOI:

Huang, Y., Wang, Q.L., Cheng, D.D., Xu, W.T. & Lu, N.H. 2016. Adhesion and invasion of gastric mucosa epithelial cells by Helicobacter pylori. Frontiers in Cellular and Infection Microbiology, 6: 159. DOI:

Ilinskaya, A.N. & Dobrovolskaia, M.A. 2016. Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future. Toxicology and Applied Pharmacology, 299: 70-77. DOI:

Janeway, C.A., Travers, P., Walport, M. & Shlomchik, M. 2001. Immunobiology. 5th Ed. Garland Science, Taylor & Francis Group, New York. 884 pp.

Jensen, K.K., Andreatta, M., Marcatili, P., Buus, S., Greenbaum, J.A., Yan, Z., Sette, A., Peters, B. & Nielsen, M. 2018. Improved methods for predicting peptide binding affinity to MHC class II molecules. Immunology, 154(3): 394-406. DOI:

Jespersen, M.C., Peters, B., Nielsen, M. & Marcatili, P. 2017. BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Research, 45: W24-W29. DOI:

Kingsley, P.V., Arunkumar, G., Tipre, M., Leader, M. & Sathiakumar, N. 2016. Pitfalls and optimal approaches to diagnose melioidosis. Asian Pacific Journal of Tropical Medicine, 9(6): 515-524. DOI:

Larsen, M.N., Lundegaard, C., Lamberth, K., Buus, S., Lund, O. & Nielsen, M. 2007. Large-scale validation of methods for sytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics, 8: 424. DOI:

Lau, S.K.P., Sridhar, S., Ho, C.C., Chow, W.N., Lee, K.C., Lam, C.W., Yuen, K.Y. & Woo, P.C.Y. 2015. Laboratory diagnosis of melioidosis: Past, present and future. Experimental Biology and Medicine, 240(6): 742-751. DOI:

Limmathurotsakul, D., Golding, N., Dance, D.A.B., Messina, J.P., Pigott, D.M., Moyes, C.L., Rolim, D.B., Bertherat, E., Day, N.P.J., Peacock, S.J. & Hay, S.I. 2016. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nature Microbiology, 1(1): 6-10. DOI:

Murphy, K. & Weaver, C. 2017. Janeway’s Immunobiology. 9th Ed. Garland Science, Taylor & Francis Group, New York. 924 pp.

Muruato, L.A., Tapia, D., Hatcher, C.L., Kalita, M., Brett, P.J., Gregory, A.E., Samuel, J.E., Titball, R.W. & Torres, A.G. 2017. Use of reverse vaccinology in the design and construction of nanoglycoconjugate vaccines against Burkholderia pseudomallei. Clinical and Vaccine Immunology, 24(11): 1-13. DOI:

Mustafa, M.J., Balingi, Menon, J., Robinson, F. & Rahman, M. 2015. Clinical manifestations, diagnosis, and treatment of Melioidosis. IOSR Journal Of Pharmacy, 5(2): 13-19.

Nathan, S., Chieng, S., Kingsley, P., Mohan, A., Podin, Y., Ooi, M.H., Mariappan, V., Vellasamy, K., Vadivelu, J., Daim, S. & How, S.H. 2018. Melioidosis in Malaysia: Incidence, clinical challenges, and advances in understanding pathogenesis. Tropical Medicine and Infectious Disease, 3(1): 25. DOI:

Nithichanon, A., Rinchai, D., Gori, A., Lassaux, P., Peri, C., Conchillio-Solé, O., Ferrer-Navarro, M., Gourlay, L.J., Nardini, M., Vila, J., Daura, X., Colombo, G., Bolognesi, M. & Lertmemonkolchai, G. 2015. Sequence-and structure-based immunoreactive epitope discovery for Burkholderia pseudomallei flagellin. PLoS Neglected Tropical Diseases, 9(7): 1-20. DOI:

Rose, N.R. 2015. Molecular mimicry and clonal deletion: A fresh look. Journal of Theoretical Biology, 375: 71-76. DOI:

Silhavy, T.J., Kahne, D. & Walker, S. 2010. The Bacterial Cell Envelope. Cold Spring Harbor Perspectives in Biology, 2(5): a000414. DOI:

Sirisinha, S., Anuntagool, N., Dharakul, T., Ekpo, P., Wongratanacheewin, S., Naigowit, P., Petchclai, B., Thamlikitkul, V. & Suputtamongkol, Y. 2000. Recent developments in laboratory diagnosis of melioidosis. Acta Tropica, 74(2-3): 235-245. DOI:

Su, Y.C., Wan, K.L., Mohamed, R. & Nathan, S. 2008. A genome level survey of Burkholderia pseudomallei immunome expressed during human infection. Microbes and Infection, 10(12-13): 1335-1345. DOI:

Su, Y.C., Wan, K.L., Mohamed, R. & Nathan, S. 2010. Immunization with the recombinant Burkholderia pseudomallei outer membrane protein Omp85 induces protective immunity in mice. Vaccine, 28(31): 5005-5011. DOI:

Virk, H.S., Mukhopadhyay, C. & Wiersinga, W.J. 2020. Melioidosis: A neglected cause of community-acquired pneumonia. Seminars in Respiratory and Critical Care Medicine, 41(4): 496-508. DOI:

Wieczorek, M., Abualrous, E.T., Sticht, J., Álvaro-Benito, M., Stolzenberg, S., Noé, F. & Freund, C. 2017. Major histocompatibility complex (MHC) class I and MHC class II proteins: Conformational plasticity in antigen presentation. Frontiers in Immunology, 8: 292. DOI:

Wiersinga, W.J., Virk, H.S., Torres, A.G., Currie, B.J., Peacock, S.J., Dance, D.A.B. & Limmathurotsakul, D. 2018. Melioidosis. Nature Reviews Disease Primers, 4: 17107. DOI:

Yu, N.Y., Wagner, J.R., Laird, M.R., Melli, G., Rey, S., Lo, R., Dao, P., Cenk, S., Ester, M., Foster, L.J. & Brinkman, F.S.L. 2010. PSORTb 3.0: Improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics, 26(13): 1608-1615. DOI:

Zhang, X., Zhang, J., Lin, Y., Xu, K., Li, N., Chen, H. & She, F. 2015. Analysis of the relationship between invasive capability of Helicobacter pylori and gastroduodenal diseases. Journal of Medical Microbiology, 64: 498-506. DOI:



How to Cite

Seow, Y. W., Tan, Z. Y., & Chieng, S. (2022). Analisis in-silico Peptida Berasaskan Epitop Daripada Protein-Protein Imunogen Burkholderia pseudomallei. Malaysian Applied Biology, 51(5), 237–247.